These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 18834830)

  • 21. Current methods to reduce the adverse haematological consequences of cardiopulmonary bypass.
    John LC; Deverall PB
    Br J Clin Pract; 1996 Jun; 50(4):203-6. PubMed ID: 8759566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet Microvesicles (Microparticles) in Cardiac Surgery.
    Tempo JA; Englyst NA; Holloway JA; Smith DC
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):222-8. PubMed ID: 26597471
    [No Abstract]   [Full Text] [Related]  

  • 23. An audit to assess the impact of new directives about the use of aprotinin on re-exploration rates and blood product usage after adult cardiac surgery.
    Khan SA; Jayarajah M; Ahlijah B
    J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):445-6. PubMed ID: 18834830
    [No Abstract]   [Full Text] [Related]  

  • 24. Aprotinin revisited.
    Deanda A; Spiess BD
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):998-1002. PubMed ID: 22795461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprotinin dosing: how much is enough?
    Niimi KS
    J Extra Corpor Technol; 2004 Dec; 36(4):384-90. PubMed ID: 15679284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
    Ngaage DL; Bland JM
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1375-83. PubMed ID: 20117944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrinolytic Therapy for Cardiac Surgery: An Update.
    Koster A; Faraoni D; Levy JH
    Anesthesiology; 2015 Jul; 123(1):214-21. PubMed ID: 25950230
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.